MIDOSTAURIN for Mastocytic leukaemia: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 36 adverse event reports in the FDA FAERS database where MIDOSTAURIN was used for Mastocytic leukaemia.
Most Reported Side Effects for MIDOSTAURIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 397 | 13.3% | 396 | 22 |
| Nausea | 252 | 8.4% | 21 | 50 |
| Febrile neutropenia | 223 | 7.5% | 33 | 90 |
| Diarrhoea | 194 | 6.5% | 29 | 59 |
| Pyrexia | 188 | 6.3% | 25 | 90 |
| Acute myeloid leukaemia recurrent | 171 | 5.7% | 29 | 14 |
| Pancytopenia | 152 | 5.1% | 11 | 25 |
| Vomiting | 152 | 5.1% | 25 | 45 |
| Drug ineffective | 151 | 5.1% | 18 | 13 |
| Thrombocytopenia | 140 | 4.7% | 17 | 37 |
| Neutropenia | 136 | 4.5% | 15 | 25 |
| Pneumonia | 128 | 4.3% | 47 | 74 |
| Bone marrow failure | 109 | 3.6% | 13 | 14 |
| Sepsis | 106 | 3.5% | 54 | 50 |
| Anaemia | 97 | 3.2% | 17 | 33 |
Other Indications for MIDOSTAURIN
Acute myeloid leukaemia (1,653)
Product used for unknown indication (688)
Systemic mastocytosis (270)
Myelodysplastic syndrome (45)
Mastocytosis (36)
Leukaemia (28)
Flt3 gene mutation (16)
Acute leukaemia (15)
Myeloid leukaemia (14)
Malignant mast cell neoplasm (13)